Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sedation, ANalgesia and Delirium MANagement: a Study of Medical, Surgical, Trauma, and Neuro-intensive Care Patients and a COVID-19 Sub-study.

NCT05027217 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT05027217
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05027217 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sedation, ANalgesia and Delirium MANagement: a Study of Medical, Surgical, Trauma, and Neuro-intensive Care Patients and a COVID-19 Sub-study.
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Completed
Start date
January 1, 2022
Completion date
May 30, 2023
Enrollment
3,421 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

analgesia, covid19, critical illness, intensive care unit delirium, sedation complication